Subscribe to Updates
Subscribe to our newsletter and never miss our latest news
Subscribe my Newsletter for New Posts & tips Let's stay updated!
Author: IQ TIMES MEDIA
Nvidia president and CEO Jensen Huang pushed back against fears of an AI bubble on the company’s blowout earnings call on Wednesday.”There’s been a lot of talk about an AI bubble,” Huang said. “From our vantage point, we see something very different.” Coming from the world’s most valuable company that powers nearly every major AI data center, that vantage point matters.Huang said that AI is fueling three transformative shifts that Nvidia is uniquely poised to capitalize on.The first stems from the slowdown of Moore’s Law — a trend that’s seen computer chips double in power roughly every two years. As…
A measles outbreak in Arizona and Utah shows no sign of slowing, putting the United States dangerously close to losing its elimination status for the vaccine-preventable disease.With holiday travel and gatherings approaching, doctors worry that transmission could escalate. If measles continues to spread through Jan. 20, that will mark a year of sustained transmission in the United States. At that point, the disease would no longer be considered eliminated and it would instead revert to being endemic, or constantly present.The backward step seems highly likely.“These pockets of communities that have low vaccination rates — if we’re not able to get…
Serena Hostvet has trouble keeping her hand steady when drawing something simple like a pumpkin, and it infuriates her.“At this point, I would just give up,” said Hostvet, 43, of Eau Claire, Wisconsin. “Art is an essential part of me. Not being able to do it as often or as well as I used to is depressing.”It’s also how she makes a living. Hostvet designs jewelry and creates original illustrations for small businesses. “Everything I do is with my hands,” she said.Hostvet has multiple sclerosis, an autoimmune disease that affects the brain and the nerves that extend from her spinal…
By Nancy Lapid(Reuters) -U.S. researchers are beginning to identify clinical characteristics that distinguish “super responders” to GLP-1 weight-loss drugs like Wegovy and Zepbound from patients who lose only moderate amounts of weight at best, according to a report published online ahead of peer review.The massive data analysis may eventually help personalize treatment decisions for the drugs already being used by millions of patients. Individual patients’ health status before starting treatment can also help guide drug selection, the analysis suggests.“If I am a clinician seeing patients, I need to know what medicine will best benefit my patient,” said study leader Venky…
Nvidia founder and CEO Jensen Huang struck a bullish tone in the company’s third-quarter earnings. And based on the company’s results, there may be reason to. Nvidia reported revenue of $57 billion in the third quarter, 62% higher compared to the same quarter last year. The company’s net income on a GAAP basis was $32 billion, 65% higher year-over-year. Both revenue and profit results beat Wall Street expectations. The revenue picture shows a company booming thanks largely to its data center business. Revenue generated by Nvidia’s data center business was a record $51.2 billion, up 25% from the previous quarter…
Yann LeCun, Meta’s chief AI scientist and one of the most influential figures in the field, is leaving the company to start a new AI venture, a Meta spokesperson confirmed to Business Insider.LeCun announced the move on Facebook, sharing that he is building a startup centered on his long-standing interest in world-model research. Meta will partner with LeCun on his new venture, a Meta spokesperson told Business Insider, but didn’t reveal any details about the nature of the partnership.LeCun’s departure comes during a period of instability inside Meta’s AI organization. Over the past few months, Meta has hired dozens of…
Business Insider’s amazing Google reporter Hugh Langley has been playing (er… working) with Google’s new Gemini 3 AI service this week.This is the latest big AI model release, competing with OpenAI’s GPT-5, xAI’s Grok 4, and the latest offerings from Anthropic.Gemini 3 is getting good reviews so far. So good that Google shares hit a record on Wednesday, putting the company’s market value very close to Microsoft.Here are Hugh’s initial thoughts, after trying Gemini 3 out for a day or so:”I think where Gemini 3 is most impressive—and where it’s already grabbing attention—is its ability to create new things from…
January Ventures co-founder Jennifer Neundorfer stopped by the Equity podcast during TechCrunch Disrupt to chat about fundraising in this very AI-driven market. Founders and investors alike are obsessed with AI, and even Neundorfer said her firm is looking at ways to use AI to make their work more efficient, such as helping to do due diligence on the market and competition. As for companies being built, she has a preference for the founders looking to create something entirely new. “Where I tend to get excited is when I see someone who is using AI to do something that isn’t 10x better. It’s…
From electronic health records and blood tests to the stream of data from wearable devices, the amount of health information people generate is accelerating rapidly. Yet, many users struggle to connect this trove of data in a meaningful way and actually use it to improve their health. Function Health, which offers a regular lab testing service to help people track their health, wants to change that by consolidating health data and making it usable for its customers by connecting that data to an AI model. To further that effort, the company recently raised $298 million in a Series B round…
As cases of potentially deadly botulism in babies who drank ByHeart infant formula continue to grow, state officials say they are still finding the recalled product on some store shelves.Investigators in at least three states found ByHeart formula for sale a week after the New York-based company recalled all products nationwide, officials told The Associated Press.At least 31 babies in 15 states who drank ByHeart formula have been hospitalized and treated for infantile botulism since August, federal health officials said Wednesday. They range in age from about 2 weeks to about 6 months, with the most recent case reported on…
